↓ Skip to main content

Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies

Overview of attention for article published in Frontiers in oncology, January 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
6 X users

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies
Published in
Frontiers in oncology, January 2023
DOI 10.3389/fonc.2023.1079034
Pubmed ID
Authors

Chiara Lazzari, Mona Rita Yacoub, Corrado Campochiaro, Alessandra Bulotta, Diego Palumbo, Francesca Rita Ogliari, Lorenzo Dagna, Silvia Marchesi, Maurilio Ponzoni, Vanesa Gregorc

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 13%
Professor 1 13%
Unknown 6 75%
Readers by discipline Count As %
Unspecified 1 13%
Agricultural and Biological Sciences 1 13%
Unknown 6 75%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2023.
All research outputs
#8,751,578
of 26,171,302 outputs
Outputs from Frontiers in oncology
#3,422
of 22,919 outputs
Outputs of similar age
#162,608
of 485,281 outputs
Outputs of similar age from Frontiers in oncology
#142
of 1,393 outputs
Altmetric has tracked 26,171,302 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 22,919 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 485,281 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 1,393 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.